Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 27, 2022
Molecular Pathways and Mechanisms of HER2 in Cancer Therapy
Kanwal P S Raghav, Mark M Moasser
Cell Chemical Biology
|
July 22, 2017
Retraction Notice to: An ATP-Competitive Inhibitor Modulates the Allosteric Function of the HER3 Pseudokinase
Peter Littlefield, Mark M Moasser, Natalia Jura
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy
Marcia R Campbell, Dhara Amin, Mark M Moasser
Seminars in Cell & Developmental Biology
|
September 7, 2010
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
Dhara N Amin, Marcia R Campbell, Mark M Moasser
Cell Cycle (Georgetown, Tex.)
|
April 15, 2011
Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state
Danislav S Spassov, Ching H Wong, Mark M Moasser
Molecular Cancer Therapeutics
|
October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers
Dhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling
Qing-Bai She, David Solit, Andrea Basso, et al.
Cell Reports
|
October 11, 2018
A Dimerization Function in the Intrinsically Disordered N-Terminal Region of Src
Danislav S Spassov, Ana Ruiz-Saenz, Amit Piple, et al.
Oncotarget
|
October 31, 2015
Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib
Dhara N Amin, Ana Ruiz-Saenz, Nathaniel Gulizia, et al.
Plos One
|
May 12, 2011
The structural features of Trask that mediate its anti-adhesive functions
Danislav S Spassov, Deepika Ahuja, Ching Hang Wong, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 27, 2022
Molecular Pathways and Mechanisms of HER2 in Cancer Therapy
Kanwal P S Raghav, Mark M Moasser
Cell Chemical Biology
|
July 22, 2017
Retraction Notice to: An ATP-Competitive Inhibitor Modulates the Allosteric Function of the HER3 Pseudokinase
Peter Littlefield, Mark M Moasser, Natalia Jura
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy
Marcia R Campbell, Dhara Amin, Mark M Moasser
Seminars in Cell & Developmental Biology
|
September 7, 2010
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
Dhara N Amin, Marcia R Campbell, Mark M Moasser
Cell Cycle (Georgetown, Tex.)
|
April 15, 2011
Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state
Danislav S Spassov, Ching H Wong, Mark M Moasser
Molecular Cancer Therapeutics
|
October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers
Dhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling
Qing-Bai She, David Solit, Andrea Basso, et al.
Cell Reports
|
October 11, 2018
A Dimerization Function in the Intrinsically Disordered N-Terminal Region of Src
Danislav S Spassov, Ana Ruiz-Saenz, Amit Piple, et al.
Oncotarget
|
October 31, 2015
Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib
Dhara N Amin, Ana Ruiz-Saenz, Nathaniel Gulizia, et al.
Plos One
|
May 12, 2011
The structural features of Trask that mediate its anti-adhesive functions
Danislav S Spassov, Deepika Ahuja, Ching Hang Wong, et al.
Page
of 6